SLIDES: FDA Approves Kisqali / Ribociclib for Early High-Risk Breast Cancer Breast 2 Mins Read41 The FDA has recently approved Kisqali (ribociclib) in combination with a non-steroidal aromatase inhibitor (NSAI) for the treatment of early-stage…
CANKADO PRO-React eHealth Support The PreCycle Trial Breast 3 Mins Read22 Nadia Harbeck, MD, PhD, from the University of Münster, recently conducted a primary outcome analysis of the multicenter randomized PreCycle…
Breast Cancer Treatment: How is Biology’s Integration into the Clinic Transforming Healthcare? Hope Rugo Breast 50 Mins Read12 Breast Cancer Treatment: How is Biology’s Integration into the Clinic Transforming Healthcare? Hope Rugo By Hope Rugo, MD, FASCO, Professor,…
